I. Introduction

On 3 August 2026, the President of the EU General Court issued an order addressing the scope of legal privilege under EU law. The order dismissed Broadcom’s application to suspend a decision by the European Commission requiring the production of documents in its investigation into Broadcom’s allegedly abusive software licensing practices.

The purpose of Broadcom’s application for interim measures was to enable it to withhold certain documents until the EU General Court rules on the main appeal against the decision.  In the main appeal, Broadcom had argued that the Commission’s decision was unlawful in so far as it compelled the production of documents that were privileged under the laws of third countries, such as the United States.

Although issued in interim proceedings and on well-established points of law, the order provides welcome guidance on the right balance between the European Commission’s investigative powers and the parties’ rights of defence. The President of the EU General Court highlights with unprecedented clarity the fundamental importance of legal privilege as a core part of procedural fairness in EU competition investigations.

That reasoning, and the further discussion on the European Commission’s practice in relation to legal advice from non-EU external lawyers, should help companies navigate the complexities of maintaining privilege over legal advice they receive, especially in global competition investigations.

The Illinois Governor recently signed SB 2886, which expands the scope of the state’s Genetic Information Privacy Act (“GIPA”) to include “biomarker testing” and “biomarker.” GIPA currently regulates the collection, use, and disclosure of genetic testing information.

The bill defines “biomarker” as “a characteristic that is objectively measured and evaluated as an indicator of…

Introduction

On August 5, 2026, NHV Group announced that its proposed acquisition by GD Helicopter Finance (“GDHF”), ultimately controlled by China-based GDAT Group, would not proceed after Belgian authorities blocked the transaction under Belgium’s foreign direct investment screening regime, following a review coordinated by the Interfederal Screening Committee (“ISC”). This marks the first public prohibition under Belgium’s foreign direct investment screening mechanism, which has been operational since July 1, 2023. The Committee did not publish detailed reasons for the decision.

While noteworthy, this should not be misread as a shift toward protectionism. Belgium’s FDI statistics show the regime has been overwhelmingly supportive of transactions. The NHV/GDHF case illustrates the regime’s core security function: transactions where critical infrastructure intersects with a geopolitically sensitive investor profile are at the heart of the ISC’s mandate. At the same time, the case sharpens existing criticisms of the regime’s opacity and complexity—criticisms that Belgian authorities are now actively addressing through a public consultation and upcoming EU-level harmonization.

On August 6, 2026, the Senate Homeland Security and Governmental Affairs Committee voted along party lines to hold Dr. Anthony Fauci in contempt of Congress.  The vote followed Dr. Fauci’s refusal to answer questions during a July 29, 2026, hearing regarding the federal government’s COVID-19 response.  The Committee referred the matter to the Department of…

Earlier this year, the Defense Security Cooperation Agency (“DSCA”) issued updated policy guidance implementing a significant expansion of the universe of countries authorized to use Foreign Military Financing (“FMF”) for direct purchases of U.S. defense items.  Previously, only ten countries were eligible for use of FMF for direct commercial contracting, and under the new guidance,…

On 29 July 2026, the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”) (the regulatory authority with responsibility for enforcing UK medical device rules) published new guidance on ambient voice technology-enabled products (“AVTs,” also known as ambient scribing tools) (“AVT Guidance”).  The AVT Guidance is intended to clarify (and essentially overrule) a decision by NHS…

On July 23, 2026, New Jersey Governor Mikie Sherrill signed A4085 (the Fair Price Protection Act) into law, which prohibits companies from charging consumers different prices for groceries based on their personal data. New Jersey will join New York, Connecticut, and Maryland in imposing prohibitions and requirements on the use of personal data in determining…

On July 7, 2026, the European Data Protection Board (“EDPB”) adopted draft Guidelines 02/2026 on Anonymisation (“Guidelines”), updating a 2014 Opinion on Anonymization Techniques. While the EDPB maintains a cautious approach to anonymization, the new Guidelines appear to offer a more structured and practical framework for assessing whether information can be considered anonymous. The Guidelines are open for public consultation until October 30, 2026.

A recent Court of Federal Claims (“COFC”) decision shows that with the right facts, the government’s failure to award a follow-on Small Business Innovation Research Program (“SBIR”) contract can be challenged at COFC.

In Strategi Consulting, LLC v. United States, the protester, Strategi, alleged that the Air Force improperly failed to award Strategi a Phase III contract for its SBIR work while assigning that Phase III work to other contractors.  The Air Force moved to dismiss, asserting that (1) there was no “procurement” and therefore COFC lacked jurisdiction under the Tucker Act, (2) the protest was barred by the Federal Acquisition Streamlining Act (“FASA”) because it related to a task order award, and (3) Strategi’s arguments lacked redressability.